Volume 70, Issue 3, Pages (September 2016)

Slides:

Advertisements

Similar presentations

Volume 64, Issue 5, Pages (November 2013)

Advertisements

Volume 71, Issue 2, Pages (February 2017)

The PSA Era is not Over for Prostate Cancer

Volume 71, Issue 6, Pages (June 2017)

Volume 69, Issue 3, Pages (March 2016)

Volume 64, Issue 6, Pages (December 2013)

Volume 64, Issue 3, Pages (September 2013)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 52, Issue 3, Pages (September 2007)

Volume 56, Issue 6, Pages (December 2009)

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 53, Issue 4, Pages (April 2008)

Volume 53, Issue 5, Pages (May 2008)

Volume 66, Issue 3, Pages (September 2014)

Volume 69, Issue 1, Pages (January 2016)

Volume 58, Issue 1, Pages (July 2010)

Volume 199, Issue 1, Pages (January 2018)

Volume 64, Issue 6, Pages (December 2013)

Diagnostic Value of MRI in a Pelvic Mass of Prostatic Origin

Volume 52, Issue 2, Pages (August 2007)

Volume 71, Issue 2, Pages (February 2017)

Prostate Cancer Epidemic in Sight?

Volume 65, Issue 6, Pages (June 2014)

Volume 66, Issue 1, Pages (July 2014)

Volume 53, Issue 2, Pages (February 2008)

Volume 50, Issue 1, Pages (July 2006)

Volume 199, Issue 4, Pages (April 2018)

Volume 64, Issue 5, Pages (November 2013)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 52, Issue 3, Pages (September 2007)

Volume 52, Issue 3, Pages (September 2007)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 53, Issue 4, Pages (April 2008)

Volume 69, Issue 3, Pages (March 2016)

Prostate Cancer Detection: A View of the Future

Volume 68, Issue 3, Pages (September 2015)

Volume 66, Issue 3, Pages (September 2014)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 69, Issue 6, Pages (June 2016)

Volume 64, Issue 3, Pages (September 2013)

Prostate Cancer Epidemic in Sight?

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

The PSA Era is not Over for Prostate Cancer

Yuanshan Cui, Yong Zhang European Urology

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 68, Issue 6, Pages (December 2015)

Volume 53, Issue 6, Pages (June 2008)

Volume 53, Issue 4, Pages (April 2008)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Tillmann Loch, Pat Fox Fulgham European Urology

Volume 68, Issue 4, Pages (October 2015)

Volume 71, Issue 6, Pages (June 2017)

Volume 68, Issue 6, Pages (December 2015)

Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.

Antonio Galfano, Silvia Secco, Aldo Massimo Bocciardi European Urology

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 75, Issue 4, Pages (April 2019)

Volume 71, Issue 3, Pages (March 2017)

European Urology is “Your” Journal

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.

How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia? Vincenzo Mirone

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Introduction European Urology Supplements

Presentation transcript:

Volume 70, Issue 3, Pages 447-455 (September 2016) Magnetic Resonance Imaging–Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial Joseph L. Chin, Michele Billia, James Relle, Matthias C. Roethke, Ionel V. Popeneciu, Timur H. Kuru, Gencay Hatiboglu, Maya B. Mueller-Wolf, Johann Motsch, Cesare Romagnoli, Zahra Kassam, Christopher C. Harle, Jason Hafron, Kiran R. Nandalur, Blaine A. Chronik, Mathieu Burtnyk, Heinz-Peter Schlemmer, Sascha Pahernik European Urology Volume 70, Issue 3, Pages 447-455 (September 2016) DOI: 10.1016/j.eururo.2015.12.029 Copyright © 2016 Terms and Conditions

Fig. 1 Treatment with magnetic resonance imaging–guided transurethral ultrasound ablation. ECD=endorectal cooling device; UA=ultrasound applicator. European Urology 2016 70, 447-455DOI: (10.1016/j.eururo.2015.12.029) Copyright © 2016 Terms and Conditions

Fig. 2 (a) Maximum temperature distribution measured during treatment; (b) Visualization of the peripheral region of enhancement surrounding the non-perfused volume on CE-MRI acquired immediately after treatment. Images are oblique-axial transverse to the UA. CE-MRI=contrast-enhanced magnetic resonance imaging; MRI=magnetic resonance imaging. European Urology 2016 70, 447-455DOI: (10.1016/j.eururo.2015.12.029) Copyright © 2016 Terms and Conditions

Fig. 3 Temporal change in continence and erectile function. CI=confidence interval; G=grade; IIEF=International Index of Erectile Function. European Urology 2016 70, 447-455DOI: (10.1016/j.eururo.2015.12.029) Copyright © 2016 Terms and Conditions